Kymera Therapeutics logo
Kymera Therapeutics KYMR
$ 40.17 2.62%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Kymera Therapeutics ROE Ratio 2011-2024 | KYMR

Annual ROE Ratio Kymera Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-37.21 -31.58 -21.8 -16.06 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.06 -37.21 -26.66

Quarterly ROE Ratio Kymera Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-33.33 -39.7 -42.47 -31.14 -39.52 -34.54 -35.74 -27.06 -32.97 -30.5 -29.94 -20.22 -23.03 -19.93 -15.3 -11.59 3.76 21.92 26.85 15.35 15.35 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
26.85 -42.47 -18.28